Accessibility Menu
 
Ventripoint Diagnostics logo

Ventripoint Diagnostics

(OTC) VPTDF

Current Price$0.10
Market Cap$19.50M
Since IPO (2011)-95%
5 Year-72%
1 Year+13%
1 Month+24%

Ventripoint Diagnostics Financials at a Glance

Market Cap

$19.50M

Revenue (TTM)

$179.92K

Net Income (TTM)

$3.20M

EPS (TTM)

$-0.01

P/E Ratio

-7.47

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$0.10

Volume

74,013

Open

$0.11

Previous Close

$0.10

Daily Range

$0.10 - $0.11

52-Week Range

$0.06 - $0.14

VPTDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

Hugh MacNaught

Headquarters

Toronto, ON M6P 1T4, CA

VPTDF Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-19%

Net Income Margin

-18%

Return on Equity

0%

Return on Capital

85%

Return on Assets

-7%

Earnings Yield

-13.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$19.50M

Shares Outstanding

187.66M

Volume

74.01K

Avg. Volume

94.62K

Financials (TTM)

Gross Profit

$118.59K

Operating Income

$3.40M

EBITDA

$3.34M

Operating Cash Flow

$1.55M

Capital Expenditure

$0.00

Free Cash Flow

$1.55M

Cash & ST Invst.

$55.34K

Total Debt

$2.60M

Ventripoint Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.30K

N/A

Gross Profit

$11.12K

N/A

Gross Margin

-2.59%

N/A

Market Cap

$19.50M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$199.59K

+81.2%

EBITDA

$722.58K

+31.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.54M

-61.6%

Accounts Receivable

$132.88K

-47.1%

Inventory

$0.00

N/A

Long Term Debt

$115.27K

-45.7%

Short Term Debt

$2.48M

+74.6%

Return on Assets

-6.78%

N/A

Return on Invested Capital

84.96%

N/A

Free Cash Flow

$598.88K

+16.9%

Operating Cash Flow

$598.88K

+16.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUMIFNuminus Wellness Inc.
$0.05+14.71%
ASAPFAurora Spine Corporation
$0.18+2.86%
LUFFFHerbal Dispatch Inc.
$0.04-2.44%
ALRTFALR Technologies Inc.
$0.01+1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About VPTDF

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at $0.10 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between $0.06 and $0.14.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of $1.90M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported $40,407.806 in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.